亿胜生物科技(01061)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01061 亿胜生物科技

未开盘 09-02 16:08:05

2.190

-0.070

-3.10%

最高2.240	最低2.120	成交量66.30万
今开2.240	昨收2.260	日振幅5.31%
总市值12.37亿	流通市值12.37亿	总股本5.65亿
成交额142.45万	换手率0.12%	流通股本5.65亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01061","market":"HK","secType":"STK","nameCN":"亿胜生物科技","latestPrice":2.19,"timestamp":1788336485602,"preClose":2.26,"halted":0,"volume":662994,"delay":0,"changeRate":-0.030973451327433562,"floatShares":565000000,"shares":565000000,"eps":0.561,"marketStatus":"未开盘","change":-0.07,"latestTime":"09-02 16:08:05","open":2.24,"high":2.24,"low":2.12,"amount":1424521,"amplitude":0.053097,"askPrice":2.19,"askSize":1000,"bidPrice":2.14,"bidSize":19000,"shortable":0,"etf":0,"ttmEps":0.468098,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788399000000},"marketStatusCode":0,"adr":0,"listingDate":993571200000,"exchange":"SEHK","adjPreClose":2.26,"dividendRate":0.054795,"openAndCloseTimeList":[[1788312600000,1788321600000],[1788325200000,1788336000000]],"volumeRatio":1.7889746357741225,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01061","defaultTab":"news","newsList":[{"id":"1189331392","title":"亿胜生物科技9月1日回购6万股股份，总额约12.99万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1189331392","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189331392?lang=zh_cn&edition=full","pubTime":"2026-09-01 17:13","pubTimestamp":1788254027,"startTime":"0","endTime":"0","summary":"亿胜生物科技于2026年9月1日发布公告称，该公司当日在香港联交所回购公司普通股60,000股。据公告，本次回购约占回购前已发行股本0.01062%，每股购回价介乎港币2.15元至2.18元，总金额为港币12.99万元。本次购回完成后，公司已发行股份数量从回购前的565,122,000股减少至565,062,000股，库藏股从1,884,000股增加至1,944,000股，总已发行股本仍为567,006,000股。公告显示，上述回购乃根据2026年5月26日股东大会通过的回购授权进行，授权总数为56,700,600股，截至公告日已累计回购1,944,000股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"亿胜生物科技9月1日回购6万股股份，总额约12.99万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664837859","title":"亿胜生物科技(01061)9月1日斥资12.99万港元回购6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664837859","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664837859?lang=zh_cn&edition=full","pubTime":"2026-09-01 17:10","pubTimestamp":1788253825,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亿胜生物科技(01061)发布公告，于2026年9月1日斥资12.99万港元回购6万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490377.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139147935","title":"亿胜生物科技更新2026年8月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1139147935","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139147935?lang=zh_cn&edition=full","pubTime":"2026-09-01 16:32","pubTimestamp":1788251529,"startTime":"0","endTime":"0","summary":"亿胜生物科技于2026年9月1日发布截至2026年8月31日的股份变动月报表。报告显示，公司本月无新增发行股份，整体股本维持稳定。根据公告，公司在报告期内进行了多笔股份回购，共计回购528,000股，回购价格介于每股2.265港元至2.3718港元之间。本月报告期内，并无因股份期权行使而增发或转换股份，公司根据此前于2023年6月9日股东大会通过的购股权计划，仍可发行或自库存转让最多57,064,900股。公司确认，截至报告期末已符合适用的公众持股量规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175879961","title":"亿胜生物科技回购4万股，耗资约9.06万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1175879961","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175879961?lang=zh_cn&edition=full","pubTime":"2026-08-24 17:11","pubTimestamp":1787562697,"startTime":"0","endTime":"0","summary":"亿胜生物科技于2026年8月24日发布公告，披露当日于香港联交所场内回购40,000股普通股，占该次回购前已发行股份的约0.00708%。本次回购每股价格最高为2.28港元、最低为2.25港元，合计耗资约90,600港元。公司确认上述回购股份将被持作库存股份。本次交易完成后，公司已发行股份数目为565,122,000股，库存股份数目为1,884,000股，合计股份总数为567,006,000股。公告显示，亿胜生物科技已就上述回购事项严格遵守香港联交所证券上市规则及相关法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿胜生物科技回购4万股，耗资约9.06万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661224118","title":"亿胜生物科技(01061)8月24日斥资9.06万港元回购4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661224118","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661224118?lang=zh_cn&edition=full","pubTime":"2026-08-24 17:01","pubTimestamp":1787562109,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亿胜生物科技(01061)发布公告，于2026年8月24日斥资9.06万港元回购4万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484211.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189870777","title":"亿胜生物科技：8月21日回购1.80万股，耗资约4.14万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1189870777","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189870777?lang=zh_cn&edition=full","pubTime":"2026-08-21 17:56","pubTimestamp":1787306194,"startTime":"0","endTime":"0","summary":"亿胜生物科技于2026年8月21日公告称，公司在香港联交所场内回购股份。是次回购数量为1.80万股普通股，对应已发行股本约0.00318%。每股回购价格为2.30港元，支付总金额约4.14万港元。回购完成后，公司已发行股本由2026年8月19日的565,180,000股变更为565,162,000股，库藏股数由1,826,000股增加至1,844,000股。截至目前，公司已于市场回购1,844,000股，占授权通过时已发行股本的0.32522%。公司确认已遵守香港联合交易所有限公司证券上市规则及其他相关法律法规的规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿胜生物科技：8月21日回购1.80万股，耗资约4.14万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661261812","title":"亿胜生物科技(01061.HK)8月21日斥资4.14万港元回购1.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661261812","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661261812?lang=zh_cn&edition=full","pubTime":"2026-08-21 17:50","pubTimestamp":1787305800,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01061","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100944434","title":"亿胜生物科技8月19日回购2万股，耗资46,000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1100944434","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100944434?lang=zh_cn&edition=full","pubTime":"2026-08-19 16:52","pubTimestamp":1787129570,"startTime":"0","endTime":"0","summary":"亿胜生物科技于2026年8月19日发布翌日披露报表，公告显示公司当日于香港联交所回购普通股20,000股，占回购前已发行股本0.00354%。本次回购每股价格为2.3港元，合计耗资46,000港元。据公告，购回授权于2026年5月26日获通过，授权可回购股数为56,700,600股，截至目前公司已累计回购1,826,000股，占购回授权通过当日已发行股本的0.32204%。公司确认已遵守香港联交所上市规则及相关法例的规定。本公告由公司董事方海洲签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿胜生物科技8月19日回购2万股，耗资46,000港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660727445","title":"亿胜生物科技(01061.HK)8月19日斥资4.6万港元回购2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2660727445","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660727445?lang=zh_cn&edition=full","pubTime":"2026-08-19 16:48","pubTimestamp":1787129309,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182437863","title":"亿胜生物科技2026年中期营收7.85亿港元，经调整净利润1.11亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1182437863","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182437863?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:53","pubTimestamp":1786524803,"startTime":"0","endTime":"0","summary":"截至2026年6月30日止六个月，亿胜生物科技录得营收7.85亿港元，同比减少10.5%。经调整净利润为1.11亿港元，同比下降32.2%。报告期内，毛利约为6.56亿港元，毛利率约83.66%，较上年同期下降5.12个百分点。行政开支增至约1.27亿港元，在营收中的占比约16.17%，同比有所上升。按分部划分，眼科业务录得营收3.67亿港元，同比下降12.0%；外科业务营收3.41亿港元，同比下滑24.0%；医疗保健及伙伴服务营收7,630万港元，较上年同期增长约646.5%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"亿胜生物科技2026年中期营收7.85亿港元，经调整净利润1.11亿港元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658978941","title":"亿胜生物科技：上半财年营收7.85亿港元，同比增长-10.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658978941","media":"南方财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658978941?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:51","pubTimestamp":1786524660,"startTime":"0","endTime":"0","summary":"南财智讯8月12日电，亿胜生物科技（01061.HK）公告，截至2026年6月30日止六个月，公司实现收益784694000港元，折合7.85亿港元；上年同期为876535000港元，同比下降10.48%。可报告分部溢利为190762000港元，折合1.91亿港元；上年同期为242068000港元。本公司拥有人应占每股盈利为19.53港仙，上年同期为28.82港仙。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608123839205731.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608123839205731.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124851893","title":"亿胜生物科技回购25.9万股股份，涉资61.43万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1124851893","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124851893?lang=zh_cn&edition=full","pubTime":"2026-08-07 16:56","pubTimestamp":1786092991,"startTime":"0","endTime":"0","summary":"2026年8月7日，亿胜生物科技有限公司于香港联交所公布翌日披露报表，披露其于当日回购普通股25.9万股，占回购前已发行股本约0.0458%。本次回购于香港联交所场内进行，每股回购价格区间为2.365港元至2.38港元，成交量加权平均价格为2.3718港元，合计动用资金614,285港元。回购的股份将作为公司库藏股持有。根据此前授权决议，亿胜生物科技获准最高回购56,700,600股，并已于各交易所累计回购180.6万股，占授权通过当日已发行股本的0.31852%，剩余可回购股份数量为5,489.46万股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿胜生物科技回购25.9万股股份，涉资61.43万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657930616","title":"亿胜生物科技(01061)8月7日斥资61.43万港元回购25.9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2657930616","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657930616?lang=zh_cn&edition=full","pubTime":"2026-08-07 16:52","pubTimestamp":1786092720,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亿胜生物科技(01061)发布公告，于2026年8月7日，该公司斥资61.43万港元回购25.9万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477333.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01061","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134030995","title":"亿胜生物科技：8月6日回购19.1万股股份，耗资约45.28万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1134030995","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134030995?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:16","pubTimestamp":1786007790,"startTime":"0","endTime":"0","summary":"2026年8月6日，亿胜生物科技发布公告，披露当日于香港联交所场内回购股份19.1万股，占回购前公司已发行股本的约0.03377%。每股回购价介乎2.36港元至2.38港元，合计支付约45.28万港元。本次回购股份将作为库藏股持有。据公告显示，截至2026年8月6日，公司已发行股本降至5.65亿股，库藏股数量增至154.7万股，已发行股份总数维持约5.67亿股。本公告由董事方海洲签署。公司并表示，本次回购相关程序均已合法合规办理。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿胜生物科技：8月6日回购19.1万股股份，耗资约45.28万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133517581","title":"亿胜生物科技中期盈利1.107亿港元，每股派息5港仙","url":"https://stock-news.laohu8.com/highlight/detail?id=1133517581","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133517581?lang=zh_cn&edition=full","pubTime":"2026-08-05 19:36","pubTimestamp":1785929798,"startTime":"0","endTime":"0","summary":"亿胜生物科技（ESSEX BIO-TECH）发布中期业绩，录得净利润1.107亿港元。公司宣布派发中期股息，每股0.05港元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171725807","title":"亿胜生物科技2026年中期营收7.85亿港元 净利1.11亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1171725807","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171725807?lang=zh_cn&edition=full","pubTime":"2026-08-05 19:31","pubTimestamp":1785929490,"startTime":"0","endTime":"0","summary":"亿胜生物科技有限公司8月5日公布，截至2026年6月30日止六个月，公司实现营业额7.85亿港元，同比下降10.5%；期内溢利1.11亿港元，同比下降32.2%。报告期内，毛利率由88.8%降至83.6%；净利率由18.6%降至14.1%。外科业务实现收入3.41亿港元，上年同期为4.49亿港元；报告期内，公司斥资265.98万港元回购1,006,000股股份，并全部保留为库藏股份。截至报告期末，公司现金及未动用银行融资额度可满足已订立的1.70亿港元资本承诺及日常运营需求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168245558","title":"亿胜生物科技(01061)宣布派发2026年中期股息 每股0.05港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1168245558","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168245558?lang=zh_cn&edition=full","pubTime":"2026-08-05 19:31","pubTimestamp":1785929467,"startTime":"0","endTime":"0","summary":"亿胜生物科技有限公司(01061)8月5日发布公告称，董事会已决议就截至2026年6月30日止六个月派发中期股息，每股0.05港元，股息性质为普通股息。派息货币为港元，适用汇率为1港元兑1港元。公司不适用代扣所得税安排。  \n  \n根据时间表，本次股息的除净日为2026年8月18日；股东欲登记获得股息，其股份过户文件须于2026年8月19日16时30分前递交香港中央证券登记有限公司。公司股份登记册将于2026年8月20日至2026年8月24日期间暂停办理过户手续，记录日期为2026年8月24日。股息派发日定于2026年9月2日。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657654914","title":"亿胜生物科技(01061)公布中期业绩 溢利约1.11亿港元 同比减少32.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657654914","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657654914?lang=zh_cn&edition=full","pubTime":"2026-08-05 19:29","pubTimestamp":1785929393,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亿胜生物科技 公布2026年中期业绩，营业额约7.85亿港元，同比减少10.5%;溢利约1.11亿港元，同比减少32.2%;每股盈利19.53港仙，拟派每股中期股息5港仙。公告称，营业额减少归因于于2026年1月30日公布并自2026年1月1日起追溯生效的中国新增值税法，改变了医药批发企业销售普通生物制品的税务处理方式。此乃由于集团无法将增加的增值税转嫁予最终客户，因为中国集中采购系统项下的包含增值税的售价是固定的，而营业额已扣除增值税。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1476431.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657496335","title":"亿胜生物科技(01061)将于9月2日派发中期股息每股0.05港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2657496335","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657496335?lang=zh_cn&edition=full","pubTime":"2026-08-05 19:28","pubTimestamp":1785929292,"startTime":"0","endTime":"0","summary":"亿胜生物科技(01061)发布公告，将于2026年9月2日派发截至2026年6月30日止六个月中期股息每股0.05港元。","market":"us","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_40.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_40.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1476430.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4585","01061","EWH","BK4588","VIG","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133544593","title":"亿胜生物科技2026年7月股份变动月报：回购350,000股并转为库存股","url":"https://stock-news.laohu8.com/highlight/detail?id=1133544593","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133544593?lang=zh_cn&edition=full","pubTime":"2026-08-03 16:49","pubTimestamp":1785746963,"startTime":"0","endTime":"0","summary":"亿胜生物科技有限公司于2026年8月3日披露截至2026年7月31日的股份变动月报，报告显示当月完成350,000股股份购回并转为库存股，整体股本保持稳定。截至2026年7月31日，已发行股份由上月底的566,000,000股减少至565,650,000股；库存股份由1,006,000股增加至1,356,000股，总股份数维持在567,006,000股。本月购回股份于2026年7月2日进行，价格为HKD 2.5586，回购后即转为库存股份，暂无注销安排。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.essexbio.com","stockEarnings":[{"period":"1week","weight":-0.0352},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1742},{"period":"6month","weight":-0.4315},{"period":"1year","weight":-0.5732},{"period":"ytd","weight":-0.3922}],"compareEarnings":[{"period":"1week","weight":-0.0133},{"period":"1month","weight":-0.0268},{"period":"3month","weight":0.0023},{"period":"6month","weight":-0.0173},{"period":"1year","weight":-0.0073},{"period":"ytd","weight":-0.0125}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"亿胜生物科技有限公司是一家主要从事生产及销售治疗体表创伤和眼部损伤生物药品的投资控股公司。该公司通过三个业务分部进行运营。外科分部主要从事开发、制造及销售贝复济液体制剂、贝复济冻干粉及贝复新凝胶以及其他产品。眼科分部从事开发、制造与销售贝复舒滴眼液、贝复舒眼用凝胶及贝复舒单剂量滴眼液以及其他产品。提供服务分部主要从事提供医疗科技电子平台相关医疗服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.733333,"avgChangeRate":0.036326},{"month":2,"riseRate":0.6,"avgChangeRate":0.051587},{"month":3,"riseRate":0.533333,"avgChangeRate":0.042832},{"month":4,"riseRate":0.466667,"avgChangeRate":0.031989},{"month":5,"riseRate":0.4,"avgChangeRate":-0.012147},{"month":6,"riseRate":0.4,"avgChangeRate":0.022585},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.0304},{"month":8,"riseRate":0.3125,"avgChangeRate":-0.005022},{"month":9,"riseRate":0.5,"avgChangeRate":0.030205},{"month":10,"riseRate":0.333333,"avgChangeRate":0.013913},{"month":11,"riseRate":0.466667,"avgChangeRate":0.008936},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.01898}],"exchange":"SEHK","name":"亿胜生物科技","nameEN":"ESSEX BIO-TECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"亿胜生物科技(01061)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供亿胜生物科技(01061)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"亿胜生物科技,01061,亿胜生物科技股票,亿胜生物科技股票老虎,亿胜生物科技股票老虎国际,亿胜生物科技行情,亿胜生物科技股票行情,亿胜生物科技股价,亿胜生物科技股市,亿胜生物科技股票价格,亿胜生物科技股票交易,亿胜生物科技股票购买,亿胜生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"亿胜生物科技(01061)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供亿胜生物科技(01061)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}